Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

MS-553 shows promise in treating chronic lymphocytic leukaemia

Enhancing cancer care in Africa: Patient perspectives and quality improvement

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL

Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer